PO-0236 HDR monotherapy for low and intermediate risk prostate cancer in one or two fractions

Autor:	D.B. Sanin, S.A. Ivanov, N.B. Borysheva, A.A. Obukhov, A.D. Kaprin, N.V. Mikhailovsky, O.B. Karyakin, O.G. Lepilina, V.A. Biryukov
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Prostate cancer business.industry Internal medicine medicine Radiology Nuclear Medicine and imaging Hematology medicine.disease business Intermediate risk
Zdroj:	Radiotherapy and Oncology. 158:S199-S200
ISSN:	0167-8140
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5862331feef9f392e3319bdabf8e9e34 https://doi.org/10.1016/s0167-8140(21)06395-7 Zobrazit plný text záznamu Full Text from ScienceDirect